Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 298

1.

Endogenous sex hormones and risk of venous thromboembolism in young women.

Scheres LJJ, van Hylckama Vlieg A, Ballieux BEPB, Fauser BCJM, Rosendaal FR, Middeldorp S, Cannegieter SC; CREW consortium.

J Thromb Haemost. 2019 May 4. doi: 10.1111/jth.14474. [Epub ahead of print]

PMID:
31054196
2.

Coronary artery calcification in middle-aged women with premature ovarian insufficiency.

Gunning MN, Meun C, van Rijn BB, Maas AHEM, Benschop L, Franx A, Boersma E, Budde RPJ, Appelman Y, Lambalk CB, Eijkemans MJC, Velthuis BK, Laven JSE, Fauser BCJM; CREW-consortium.

Clin Endocrinol (Oxf). 2019 May 2. doi: 10.1111/cen.14003. [Epub ahead of print]

PMID:
31049984
3.

Diagnosing and treating antiphospholipid syndrome: a consensus paper.

Limper M, de Leeuw K, Lely AT, Westerink J, Teng YKO, Eikenboom J, Otter S, Jansen AJG, V D Ree M, Spierings J, Kruyt ND, van der Molen R, Middeldorp S, Leebeek FWG, Bijl M, Urbanus RT.

Neth J Med. 2019 Apr;77(3):98-108.

4.

Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis.

Klaassen ILM, Lauw MN, Fiocco M, van der Sluis IM, Pieters R, Middeldorp S, van de Wetering MD, de Groot-Kruseman HA, van Ommen CH.

Res Pract Thromb Haemost. 2019 Feb 27;3(2):234-241. doi: 10.1002/rth2.12182. eCollection 2019 Apr.

5.

Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.

Ende-Verhaar YM, Meijboom LJ, Kroft LJM, Beenen LFM, Boon GJAM, Middeldorp S, Nossent EJ, Symersky P, Huisman MV, Bogaard HJ, Noordegraaf AV, Klok FA.

J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31424-X. doi: 10.1016/j.healun.2019.03.003. [Epub ahead of print]

PMID:
30962147
6.

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865.

PMID:
30893534
7.

Creatine kinase and blood pressure in women with a history of early-onset preeclampsia.

Horjus DL, Bokslag A, Hooijberg F, Hutten BA, Middeldorp S, de Groot CJM.

Pregnancy Hypertens. 2019 Jan;15:118-122. doi: 10.1016/j.preghy.2018.12.009. Epub 2018 Dec 31.

PMID:
30825907
8.

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators.

N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7.

PMID:
30730782
9.

Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis.

Silvis SM, Lindgren E, Hiltunen S, Devasagayam S, Scheres LJ, Jood K, Zuurbier SM, Kleinig TJ, Silver FL, Mandell DM, Middeldorp S, Putaala J, Cannegieter SC, Tatlisumak T, Coutinho JM.

Stroke. 2019 Feb;50(2):501-503. doi: 10.1161/STROKEAHA.118.023017.

PMID:
30621526
10.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, Vazquez SR, Greer IA, Riva JJ, Bhatt M, Schwab N, Barrett D, LaHaye A, Rochwerg B.

Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802. Review.

11.

Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis.

Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S, Konstantinides SV, Barco S.

Thromb Res. 2018 Dec;172:74-79. doi: 10.1016/j.thromres.2018.10.025. Epub 2018 Oct 26.

PMID:
30384038
12.

Treatment of Lower Extremity Superficial Thrombophlebitis.

Di Nisio M, Wichers I, Middeldorp S.

JAMA. 2018 Dec 11;320(22):2367-2368. doi: 10.1001/jama.2018.16623.

PMID:
30383173
13.

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials.

Scheres LJJ, Lijfering WM, Middeldorp S, Cheung YW, Barco S, Cannegieter SC, Coppens M.

Res Pract Thromb Haemost. 2018 Aug 18;2(4):689-695. doi: 10.1002/rth2.12142. eCollection 2018 Oct.

14.

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis.

Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA.

Lancet Haematol. 2018 Nov;5(11):e512-e519. doi: 10.1016/S2352-3026(18)30151-0. Epub 2018 Oct 9.

PMID:
30314712
15.

Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Amin EE, Bistervels IM, Meijer K, Tick LW, Middeldorp S, Mostard G, van de Poel M, Serné EH, Otten HM, Klappe EM, Joore MA, Ten Cate H, Ten Wolde M, Ten Cate-Hoek AJ.

Blood. 2018 Nov 22;132(21):2298-2304. doi: 10.1182/blood-2018-03-836783. Epub 2018 Sep 20.

16.

Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy.

Dam V, Onland-Moret NC, Verschuren WMM, Boer JMA, Benschop L, Franx A, Moons KGM, Boersma E, van der Schouw YT; CREW-consortium.

Heart. 2018 Sep 12. pii: heartjnl-2018-313439. doi: 10.1136/heartjnl-2018-313439. [Epub ahead of print]

PMID:
30209122
17.

Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

van der Pol LM, Bistervels IM, van Mens TE, van der Hulle T, Beenen LFM, den Exter PL, Kroft LJM, Mairuhu ATA, Middeldorp S, van Werkhoven JM, Ten Wolde M, Huisman MV, Klok FA.

Br J Haematol. 2018 Nov;183(4):629-635. doi: 10.1111/bjh.15556. Epub 2018 Sep 10.

18.

Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.

Bleker SM, Brekelmans MPA, Eerenberg ES, Cohen AT, Middeldorp S, Raskob G, Büller HR.

Thromb Haemost. 2017 Oct;117(10):1944-1951. doi: 10.1160/TH16-12-0946. Epub 2017 Nov 28.

PMID:
30151820
19.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

20.

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

Ten Cate H, Lensing AWA, Weitz JI, Middeldorp S, Beyer-Westendorf J, Kubitza D, Brighton T, Raskob GE, Mismetti P, Prandoni P, Gebel M, Prins MH.

Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15.

PMID:
30121419

Supplemental Content

Loading ...
Support Center